WASHINGTON – The first new drug against Alzheimer’s disease in nearly two decades received a conditional and controversial green light from U.S. drug regulators on Monday. The U.S. Food and

Western military experts are assessing whether an autonomous drone operated by artificial intelligence, or AI, killed people — in Libya last year — for the first time without a human